Canada is Leading the Fight to End AIDS, TB and Malaria for Good

 

Introduction by Patrick Bidulka 

McGill University was fortunate to participate in the Global Fund Replenishment conference held in Montreal this September. The Global Fund side event at McGill, organized by the McGill Global Health Programs office, saw a high turn-out of world-class global health researchers and students. With its contribution of nearly $800 million, Canada has repositioned itself as a key contributor to the field of global health, and a stakeholder in the mission of the Global Fund to end HIV/AIDS, TB, and Malaria for good. However, as the Honorable Jane Philpott said as she addressed the event, these goals will not translate into tangible results until society collectively deems current health disparities as “outrageous, and solvable”. It is outrageous that a third of the world is infected with TB, with the majority of those infected being in developing countries. It is outrageous that here in Canada, we have a TB epidemic concentrated in our Aboriginal communities, where the rate of TB in Indigenous populations is 34 times higher than in non-Indigenous Canadians. It is outrageous that here in Canada, there are 50 new infections of HIV every week, and this rate has not changed in the last two decades. And so, it is these glaring inequalities that must be recognized, and deemed outrageous by more than just researchers and health care workers, but collectively by the global population. Progress has been paralyzed by barriers such as stigma, racism, gender inequality, and prejudice against LGBTQ people. It is not until these basic issues surrounding human rights are resolved that we can truly put an end to AIDS, TB and Malaria. As Mark Dybul, CEO of The Global Fund said at the McGill side event, “To end these diseases, we must become better humans”.

Panelists at the McGill event (from left to right): the Honourable Jane Philpott, Mark Dybul, Lucica Ditiu, Peter Singer, Mark Wainberg, Philippe Gros, and Marcel Behr.

Panelists at the McGill event (from left to right): the Honourable Jane Philpott, Mark Dybul, Lucica Ditiu, Peter Singer, Mark Wainberg, Philippe Gros, and Marcel Behr.

_____________________________________________________________________________________

Dr. Madhukar Pai & Dr. David Eidelman

As Montreal gears up to host the biggest leaders in global health, it is our hope that Canada will go well beyond provision of international aid, and find a way to harness the abundant scientific talent in Canada. Doing so will not only amplify the financial contributions by Canadians, but also show our global solidarity.

The past year has seen the re-emergence of Canada in the international development arena. In addition to maternal and child health, if there is one area where Canada is showing tremendous leadership, it is in the fight against the “big three” — AIDS, tuberculosis, and malaria — infections that kill over 3 million people each year.

To tackle the big three, The Global Fund to Fight AIDS, TB and Malaria was created in 2002. The Global Fund raises resources, engages a variety of partners, and invests funds in supporting programs to tackle the epidemics. Programs supported by theGlobal Fund have saved 20 million lives, by providing 9.2 million people with antiretroviral therapy for HIV, 15.1 million people with testing and treatment for TB, and 659 million mosquito bed nets to prevent malaria.

Canada is blessed with some of the best academic researchers and innovators working in global health.

If the Global Fund is to continue making progress towards ending these epidemics for good, it needs to be replenished by donor governments, private foundations, corporations, and philanthropists — and Canada is showing the world how to get this done!

On September 16-17, 2016, the Government of Canada will host the Fifth Replenishment Conference in Montreal that will bring world leaders to set funding for the next three years. The Global Fund has set a target of raising US$13 billion. Canada has already pledged CAN$785 million, a 20 increase compared to the last round. The USA has pledged up to US$4.3 billion, France has pledged €1.08 billion, and Germany has pledged €800 million. These pledges, hopefully, will inspire others to contribute and meet the target of US $13 billion which can save an additional 8 million lives.

In addition to supporting the Global Fund, the Government of Canada has made a renewed investment of CAN$85 million for the Stop TB Partnership’s TB REACH initiative, to reach, treat and cure many of the 3.6 million people affected by TB who every year go without proper care. The Government of Canada has also invested inGrand Challenges Canada, an agency that is funding several innovative projects in TB, HIV and Malaria.

We can be proud of all these developments that show commitment and leadership from the Canadian Government. However, in addition to providing development assistance, Canada has much more to offer. Canada is blessed with some of the best academic researchers and innovators working in global health. For example, an experimental Ebola vaccine developed by Canadian scientists has already attracted international attention.

In the area of HIV, TB and Malaria, Canadian researchers are making valuable contributions. Canada has led the way in identification of anti-retroviral drug targets, development and promotion of the Treatment as Prevention strategy, development and evaluation of new diagnostics, treatment of HIV and hepatitis co-infections, and leadership roles in prestigious societies to influence policy and advocacy.

Epidemics such as SARS, Ebola and Zika have shown us that infectious diseases respect no boundaries.

Canada has a rich history of research in tuberculosis, a disease that still affects our Aboriginal communities. Canadian researchers have identified the genetic basis of susceptibility to TB, used innovative DNA fingerprinting methods to track the epidemic, evaluated novel tests for TB, conducted clinical trials to develop shorter drug therapies, and contributed to international policies. Canadian researchers have identified promising malaria drug targets, documented malaria strain variations, and developed a global molecular surveillance system for drug-resistant malaria.

McGill University and its affiliated hospitals are home to several teams that focus on HIV, TB and parasitic diseases. With over 100 scientists working on infectious diseases, McGill has much to offer in global health, from fundamental science to policy, and, in particular, training of the next generation of researchers. McGill Global Health Programs coordinates the University’s global health work, and is making strategic investments and partnerships to make sure McGill’s faculty and students are actively engaged as global citizens, in solving the biggest global health challenges.

Epidemics such as SARS, Ebola and Zika have shown us that infectious diseases respect no boundaries. We are excited that Canada is showing impressive leadership in global health, and particularly thrilled that the Global Fund Replenishment Conference is being held in Montreal. We hope the Global Fund replenishment targets will be met, and Canadian researchers will be actively engaged to translate the dollars into saved lives.

Madhukar Pai is the Director of McGill Global Health Programs, and the Associate Director of McGill International Tuberculosis Centre. (@paimadhu)

David Eidelman is the Vice Principal of Health Affairs at McGill University, and Dean of the Faculty of Medicine. (@VPDeanEidelman)

This article was originally published in The Huffington Post. See the original article here.

Notes from the AIDS2016 Conference in Durban, South Africa

Kara Leigh Redden

In July, I had the amazing opportunity to not only participate in the AIDS2016 International AIDS Conference in Durban, South Africa, but to also present my research on the prevention of mother-to-child transmission of HIV with my Haitian co-investigator.

Kara and her co-investigator presenting their work at the AIDS2016 conference in Durban, South Africa.

Kara and her co-investigator presenting their work at the AIDS2016 conference in Durban, South Africa.

It was our first time in South Africa and our first time at such an internationally organized event focused on HIV/AIDS. The weeklong conference was jam packed with activities, events, speaker series, presentations and much more—so much more that it was impossible to fit everything in the five days we were there.

Among the many leaders speaking, we heard from Charlize Theron on the importance of recognizing HIV/AIDS as a human rights issue.

Actress Charlize Theron speaking on human rights issues surrounding HIV/AIDS.

Actress Charlize Theron speaking on human rights issues surrounding HIV/AIDS.

We also heard from Elton John and Prince Harry remarking on the importance of recognizing youth’s voices and vulnerability in efforts to end the burden of HIV/AIDS.

Sir Elton John speaking at the AIDS2016 conference.

Sir Elton John speaking on youth vulnerability at the AIDS2016 conference.

Most impressive was the participation of some of the most vulnerable groups affected by HIV—healthcare workers, trans-men and -women, sex workers, homeless populations, and members of aboriginal communities as well as the lesbian and gay community. While we still have a long way to go to ensure that the voices of these groups are represented, it was refreshing to be among those who are the most affected by HIV and the barriers that affect access to HIV care and services.  Because of this, we were graced by many leading HIV/AIDS activists who have spent their life standing up to big corporations and governments to make sure that those who need care the most can get access to that care.

Any trip to South Africa would not have been complete without paying homage to the great Nelson Mandela. We visited Mandela’s capture site where a monument was erected in his honour, constructed out of the very bars that held him captive for over 27 years.  I hope that he would have been proud of the great work being done in his country.

The monument marking Nelson Mandela's capture site in the South African province of KwaZulu-Natal.

The monument commemorating Nelson Mandela’s capture site in the South African province of KwaZulu-Natal.

Kara graduated in May 2016 with a Masters of Nursing and a concentration in Global Health Studies. During her studies, she travelled to Haiti to conduct research on the prevention of mother-to-child transmission in collaboration with their partner site, Zanmi Lasante. Kara has been involved in various Global Health activities since 2012 and hopes to continue to contribute to this field as a nurse.

Elise in Haiti: Post-Travel Report

 
 
 
 
 
 
 
 
 
By: Elise Vuille-Lessard

Award won:

The Global Health Travel Award for Postgraduate Medical Residents

Bio:

I am a PYG-3 in internal medicine based at the Royal Victoria Hospital. What made me want to participate in the McGill Internal Medicine Global Health Initiative in Haiti was the idea of a long-term partnership between McGill and Haitian doctors and of capacity building, rather than a one-time intervention.

Project Overview:

elise_photo

Elise in Haiti

This project is a one-month elective rotation where a team composed of internal medicine senior residents and staff from McGill works at Hopital St-Nicolas (HSN) in St-Marc, Haiti. This involves collaborating with local residents and staff as well as Zanmi Lasante/Partners in Health (ZL/PIH), the largest non-government health care provider in Haiti. The goal of this project is to maintain a partnership with ZL and the family medicine program at HSN (including exchanging knowledge, teaching, mentoring), while developing competencies for McGill residents in global health.

Lessons learned:

Change is so difficult to implement. Last year’s team had tried to implement the concept of a patient list on the ward, using whiteboards where you put the patient age, sex, diagnosis and plan. Unfortunately, the first day we arrived to the hospital, the whiteboards were empty. We re-emphasised this concept and did some positive reinforcement throughout the month, and finally the boards were being used when we left. Our fear was that residents would stop using them after we left, but 1 month later we were excited to learn that they were still in use. Change IS possible! I was sometimes discouraged thinking what we were doing was a wasted effort, that those interventions we were making would not stay. But when I learned that the whiteboards were still in use after we were gone, I suddenly felt like I had done something good and valuable.

Advice:

Students looking for a global health experience need to find a project that involves a long-term relationship with the local workers and try to avoid sporadic interventions. The main reason for that is that the time spent on-site is limited and maintaining the change afterwards becomes the most difficult challenge. One of the terms I learned with this project is “capacity building”, which includes finding ways of making an intervention sustainable.

 

This experience influenced my future career plans in many ways. I don’t know when I will participate again in a global health initiative, maybe not in the near future, but possibly later in my professional life. One thing this experience did reinforce is my desire to be a teacher. I certainly want to work in an academic setting and teach young people how to become better doctors, in regards to the medicine itself but also the human side of it.

 

Blog authors are solely responsible for the content of the blogs listed in the directory. Neither the content of these blogs, nor the links to other web sites, are screened, approved, reviewed or endorsed by McGill University. The text and other material on these blogs are the opinion of the specific author and are not statements of advice, opinion, or information of McGill.